Form D · Biotechnology

Comera Life Sciences Holdings, Inc.

Woburn, MA · CIK 0001907685

Offering snapshot reported Jan 8, 2024 · SEC filing

Reported sold
$1.5M
Offering amount: $1.5M
Investors reported
12
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 29, 2023
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 8, 2024Initial$1,500,000No comparison12SEC filing
Aug 7, 2023Initial$2,249,000No comparison12SEC filing
Aug 7, 2023Initial$238,336No comparison1SEC filing
Jan 12, 2023Initial$3,561,250No comparison14SEC filing

Offering details

Securities
Debt, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-501778

Source: Form D, filed Jan 8, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Sirshendu Roopom Banerjee Director
Michael Gerard Campbell Executive
Dorothy J. Clarke Director
Kirsten Flowers Director
Jeffrey S. Hackman Director, Executive
Robert Patrick Mahoney Executive
Janice Marie Mc Court Executive
Neal Muni Executive
Stuart A. Randle Director
James Sherblom Director
Edward Aloysius Sullivan Jr. Director
William A. Wexler Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
12 Gill Street Suite 4650
Woburn, MA, 01801